Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives

Ema Ozaki,1 Matthew Campbell,1 Sarah L Doyle2,3 1Department of Genetics, 2Department of Clinical Medicine, School of Medicine, Trinity College Dublin, 3National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland Abstract: The inflammasome is...

Full description

Bibliographic Details
Main Authors:	Ozaki E, Campbell M, Doyle SL
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-01-01
Series:	Journal of Inflammation Research
Online Access:	http://www.dovepress.com/targeting-the-nlrp3-inflammasome-in-chronic-inflammatory-diseases-curr-peer-reviewed-article-JIR

Similar Items

NLRP3 Inflammasome and Inflammatory Diseases
by: Zheng Wang, et al.
Published: (2020-01-01)

NLRP3 Inflammasome and Inflammatory Bowel Disease
by: Yu Zhen, et al.
Published: (2019-02-01)

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
by: Congfei Xu, et al.
Published: (2018-10-01)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

NLRP3 Inflammasome and Pathobiology in AMD
by: Lucia Celkova, et al.
Published: (2015-01-01)

Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
by: Qiu-Ling Chen, et al.
Published: (2021-06-01)

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
by: Yucheng Wang, et al.
Published: (2020-03-01)

The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
by: Ruixiang Chen, et al.
Published: (2021-03-01)

NLRP3 inflammasome: the core mechanism and potential target of inflammatory response in Alzheimer's disease
by: Jian-quan SHI, et al.
Published: (2020-01-01)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
by: Bo-Zong Shao, et al.
Published: (2018-09-01)

Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
by: Xiaoqin Wu, et al.
Published: (2017-12-01)

Targeting the NLRP3 Inflammasome via BTK
by: Alexander N. R. Weber, et al.
Published: (2021-02-01)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021-03-01)

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
by: Yi Huang, et al.
Published: (2018-04-01)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
by: Yadi Guan, et al.
Published: (2020-07-01)

NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.
by: Simona Granata, et al.
Published: (2015-01-01)

The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases
by: Shizhen Zhao, et al.
Published: (2021-05-01)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
by: Mahbuba Akther, et al.
Published: (2021-08-01)

Targeting the NLRP3 Inflammasome in Severe COVID-19
by: Tracey L. Freeman, et al.
Published: (2020-06-01)

Targeting NLRP3 Inflammasome Activation in Severe Asthma
by: Efthymia Theofani, et al.
Published: (2019-10-01)

Modulation of the inflammatory response to biomaterials: Macrophages and NLRP3 inflammasome
by: Daniela Fernanda Pereira de Vasconcelos
Published: (2020)

Role of the NLRP3 inflammasome in autoimmune diseases
by: Zhe Li, et al.
Published: (2020-10-01)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
by: Eleonora Mezzaroma, et al.
Published: (2021-02-01)

Focus on the Role of NLRP3 Inflammasome in Diseases
by: Roberta Fusco, et al.
Published: (2020-06-01)

The role of the NLRP3 inflammasome in pulmonary diseases
by: Nima Hosseinian, et al.
Published: (2015-08-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
by: Qingying Yu, et al.
Published: (2021-08-01)

The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
by: Rongrong Bai, et al.
Published: (2021-05-01)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
by: Nan Ding, et al.
Published: (2020-12-01)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018-09-01)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)

Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease
by: Hua Bai, et al.
Published: (2021-07-01)

The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
by: Ya-Shuo Feng, et al.
Published: (2021-06-01)

The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease
by: Kendra L. Hanslik, et al.
Published: (2020-09-01)

Metaflammation, NLRP3 Inflammasome Obesity and Metabolic Disease
by: Anna Meiliana, et al.
Published: (2011-12-01)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
by: Ge Zhang, et al.
Published: (2021-06-01)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
by: Gulcin Tezcan, et al.
Published: (2021-02-01)

Enhanced Autolysosomal Function Ameliorates the Inflammatory Response Mediated by the NLRP3 Inflammasome in Alzheimer’s Disease
by: Wen Zhou, et al.
Published: (2021-02-01)

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
by: Carolina Pellegrini, et al.
Published: (2019-06-01)

Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
by: Na An, et al.
Published: (2019-07-01)